The study reveals that Molnupiravir is an oral and antiviral drug by Merck against Covid-19. It promises to reduce the risk of hospitalization or death in sufferers who have mild or moderate COVID-19. It is the first oral antiviral medication found to be helpful against this pandemic which has taken millions of lives.
